
- Telehealth Visits
- Insurance plan information

Anne Kinderman, MD
Oncology Palliative Medicine • Palliative Medicine- Telehealth Visits
- Insurance plan information



Anne Kinderman, MD
Oncology Palliative Medicine • Palliative Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Anne Kinderman is a palliative care specialist who works with patients experiencing serious illness, including cancer. Seeking to integrate the full context of each individual's life into her care, she focuses on helping patients live as well as possible while they face the challenges that accompany serious illness. Her patients come from diverse geographic locations and life situations, and she is committed to understanding their unique values, priorities and concerns in order to help them make the best decisions for their care.
Kinderman's research interests include expanding access to high-quality palliative care for patients insured by Medicaid, promoting best practices in communication for patients who have limited proficiency in the English language, and developing palliative care programs in safety net health systems.
Kinderman earned her medical degree at Rush Medical College. She completed a residency in internal medicine at UCSF and a fellowship in hospice and palliative medicine at Stanford University. Prior to joining UCSF, she worked for many years at Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) as the founding director of its Supportive and Palliative Care Service. In this role, she cared for patients with diverse cultural and linguistic backgrounds, socioeconomic statuses, social connections and types of illness.
Kinderman has won awards for her work in palliative medicine, including the Commitment to Patient Care Award from the UCSF Symptom Management Service, an award for subspecialty consultant of the year from ZSFG, and an inspiring leader under 40 award from the American Academy of Hospice and Palliative Medicine.
Education & training
Board certification
- Hospice & Palliative Medicine, American Board of IM/Hospice & Palliative Medicine
Fellowship
- Hospice & Palliative Medicine, Stanford University School of Medicine
- Internal Medicine, UCSF Graduate Medical Education
Residency
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, Rush Medical College
My expertise
Locations
My research
Publications
Showing 1-6 of 15 reviews
- October 22, 20255 out of 5 Stars
Doc Kinderman listens, she make suggestions based upon research, wears her humanity on her sleeve I truly appreciate her continued care.
- September 3, 20255 out of 5 Stars
Doc.Kinderman has my most current information, always prepared with informed suggestions, a wonderful listener, always welcoming and wears her humanity on her sleeve. I thank her for her continued care.
- June 25, 20255 out of 5 Stars
Dr. Kinderman is one of a kind. Always prepared with the most current information regarding my health. Dr. Kinderman listens and not just to respond. I trust her care implicitly.
- June 18, 20255 out of 5 Stars
No trouble at all.
- April 22, 20255 out of 5 Stars
All of the Palliative Care people have been top shelf. Dr Kindermann stands out to me but that. May be just that I have had more contact. UCSF has always been the best but Dr Kindermann has really made me feel like my viewpoint was important. And even though I leave long half- coherent messages at 2 or 3 in the morning they get responses faster than I expect. So nice (and rare) in this field.
- April 16, 20255 out of 5 Stars
Doc Kinderman is one of a kind. Listening is her wonderful skill, being informed regarding changes in my health and meds a professional with a kind and compassionate spirit.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.